Even though the identification of conolidine as a potential novel analgesic agent presents an extra avenue to handle the opioid disaster and regulate CNCP, further more reports

" To date, the compound has demonstrated remarkably several, if any, Negative effects, but that is a thing of a double-edged sword. "The lack of Uncomfortable side effects can

The liver enzymes crack it down into several metabolites, many of which can even have analgesic Houses. Knowing this metabolic pathway reassured me that Conolidine is processed